NCT03862378

Brief Summary

In our previous study, a nomogram model was established to predict intra-abdominal infectious complications after gastrointestinal surgery. This model was based on the clinical data and the drainage fluid cytokine levels, and it received an AUC \>0.9. In this study, validation of this nomogram is planned to be conducted in this prospective cohort study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 31, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 5, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

June 11, 2019

Status Verified

June 1, 2019

Enrollment Period

2 years

First QC Date

January 31, 2019

Last Update Submit

June 8, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Predictive value of the nomogram prediction model (APPEAL-GC score)

    The positive predictive value of the APPEAL-GC score in predicting the intra-abdominal infectious complications. Intra-Abdominal infectious complications include anastomotic leakage and other abdominal infectious complications. The complication definitions are in accordance with the Chinese consensus of gastrointestinal complication diagnosis and registration. The APPEAL-GC score was derived from our recently finished study (unpublished). It includes evaluation of the surgical type (open or laparoscopic), resection range, age, and cytokine levels on the postoperative day 3. A score of each patient can be determined, and a pre-set cut-off value (unpublished data) was determined in our previous study based on the AUC analysis. In this study, each patient will be scored accordingly. The positive predictive value and negative predictive value of the cut-off value will be evaluated.

    From surgery until discharge, up to 90 days.

Secondary Outcomes (2)

  • Abdominal infection rate.

    From surgery until discharge, up to 90 days.

  • Abdominal infection outcome.

    From surgery until discharge, up to 90 days.

Study Arms (1)

Group One

All patients underwent gastric or colorectal cancer surgery in the participating centers will be included. Clinical data, drainage cytokine levels will be recorded.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This observational study intends to include all patients undergoing gastric or colorectal cancer with primary anastomosis. Because drainage fluid analysis is necessary for the prediction model, patients without the tube will be excluded.

You may qualify if:

  • Planned surgery for gastric or colorectal cancer with primary anastomosis.
  • Inform consent signed before surgery.

You may not qualify if:

  • No drainage tube placed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University Cancer Hospital & Institute

Beijing, Beijing Municipality, 100142, China

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

In this study, we will collect the discarded drainage fluid for each patient for further analysis. The samples will be collected and stored in -80 refrigerators until analysis. The candidate targets include IL-1, IL-6, IL-10, TNF-a, MMP2, MMP9.

MeSH Terms

Conditions

Anastomotic LeakIntraabdominal InfectionsGastrointestinal Neoplasms

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsInfectionsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal Diseases

Study Officials

  • Ziyu Li, MD PhD

    Peking University Cancer Hospital & Institute

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zhouqiao Wu, MD PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 31, 2019

First Posted

March 5, 2019

Study Start

January 1, 2019

Primary Completion

December 31, 2020

Study Completion

December 31, 2021

Last Updated

June 11, 2019

Record last verified: 2019-06

Locations